PLx Pharma Inc. to Discuss 2020 Third Quarter Financial Results on November 13, 2020 Conference Call and Provide Business Update
SPARTA, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard™ delivery system to provide …